Christian Petersen lives in Denmark and has type 2 diabetes.

DISEASE AREAS

Type 2 diabetes

Discovering new treatments for type 2 diabetes

Christian Petersen lives in Denmark and has type 2 diabetes.

Type 2 diabetes

Type 2 diabetes is a complex chronic disease that occurs when the body cannot make enough insulin or use it effectively. People living with type 2 diabetes need treatment in order to keep their insulin and blood sugar levels under control.

Insulin is a hormone made by the pancreas that controls the amount of glucose in the blood. Too little insulin means the body cannot absorb glucose from the food we eat. When this happens, blood glucose levels rise, and over time, these increased levels can damage blood vessels and reduce the supply of oxygen and nutrient-rich blood to the body’s organs and nerves.

People living with type 2 diabetes, whose bodies do not respond well, or are resistant to insulin, may need treatment to help their bodies better process glucose. This can help prevent long-term complications.

Every day, we are working to improve treatment options for people living with type 2 diabetes. From more effective medicines to the way they are taken, we leave no stone unturned.

The facts of type 2 diabetes

90%

of all diabetes cases are type 2 diabetes globally.

380m

people live with type 2 diabetes globally.

2-4x

the increased risk of cardiovascular disease.

7x

the increased risk of developing type 2 diabetes for someone living with obesity.

Type 2 diabetes illustration displaying a city outline.

A strong pipeline focused on the patients’ needs

For almost 100 years, we have discovering new ways insulin is injected. This has been driven by our commitment to make drug delivery as simple and convenient as possible.

Our starting place is the people living with type 2 diabetes, listening to their challenges when self-treating, and understanding how to make treatment better tolerated and easier.

We use scientific methods from anthropology to biochemistry to provide data and direction to our research and engineering skills, and experience.

Within the field of type 2 diabetes, we are currently researching into the following areas:

  • Glucose-responsive insulins
  • Connected devices
  • Oral antidiabetics
  • Cardiovascular benefit
  • Weight reduction